Vaccines
Antibodies are our major defense against these small, efficient viruses. Vaccines prime the immune system with antibodies, making it ready to fight an infection. In the case of poliovirus, there are two types of vaccines. One is a killed version of the virus, which is slowly killed with formaldehyde over the course of several days so that it is inactivated, but still keeps its proper shape. The second is a weakened, but still live, strain of the virus that has been artificially bred to stimulate the immune system without causing disease. The immune system responds by making antibodies to fight these weakened viruses, leaving it ready to fight the real thing when it comes along.
The polio vaccines are one of the triumphs of modern medicine, but many people would say that the lack of a cure for the common cold is one of the great failings. The difficulty of creating a vaccine for the common cold lies in the diversity of rhinovirus. Over one hundred types of rhinovirus have been discovered as they strike people around the world, and new strains appear continually. Rhinovirus is a moving target that is not effectively combated with a single vaccine. Antiviral drugs, however, are a possible solution.
Picornavirus Structure
Many viruses, including the picornaviruses and bacteriophage phiX174 (discussed in an earlier Molecule of the Month), are icosahedral in shape. They are composed of 60 identical pieces that form a perfectly symmetrical shell, termed a capsid, around the viral genome. In the case of poliovirus and rhinovirus, the shell is composed of 60 copies of four different proteins (colored yellow, orange, red, and magenta on rhinovirus here, PDB entry 4rhv), for a total of 240 protein chains in all. Notice that the fourth chain, colored magenta, can only be seen on the inside surface of the capsid. These proteins are carefully designed to be stable, but not too stable. They must be fairly sturdy to allow the virus to pass from host to host through the hostile environment. But at the same time, they must be able to fall apart when they enter the cell, releasing the RNA inside. A carefully orchestrated Little RNA Viruses Viruses are biological hijackers. They attack a living cell and force it to make many new viruses, often destroying the cell in the process. Picornaviruses, or "little RNA viruses," are among the most simple viruses. They are composed of a modular protein shell, which seeks out and binds to a target cell surface, surrounding a short piece of RNA, which contains all of the information needed to co-opt the cell's machinery and direct the construction of new viruses. In spite of their simplicity, or perhaps because of it, the picornaviruses are also among the most important viruses for human health and welfare. Three familiar examples are shown here: poliovirus on the left (PDB entry 2plv), rhinovirus in the center (PDB entry 4rhv), and the virus that causes foot and mouth disease in livestock on the right (PDB entry 1 bbt). set of structural changes occur as the virus attaches to the surface of the cell and is drawn inside, allowing the virus to deliver its RNA into the unwitting host.
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The RNA protected inside the capsid is seen only as a blurry tangle in these crystallographic structures and is not shown in these pictures, because it is not as perfectly symmetrical as the many proteins in the shell. The rhinovirus genome, when analyzed by sequencing techniques, contains just enough information to direct the construction of eleven proteins. These include the four separate proteins for its capsid, another four proteins that replicate its RNA, two proteins to clip each of these proteins into the proper shape, and one additional protein with as-yet obscure function.
Antibody Protection
Antibodies bind to the surface of picornaviruses and stop them from attacking cells. In the left picture, rhinovirus is bound to a receptor protein on the cell surface, shown in blue (from PDB entry 1dgi). Notice that the receptor protein is gripped within a groove that encircles the five-fold symmetrical arrangement of proteins shown in yellow (known as the canyon in the picornavirus literature). Antibodies bind to the surface of rhinovirus and poliovirus in this same position and block their attachment to the surfaces of cells. The right picture shows fragments of antibodies (in light blue) bound to rhinovirus (from PDB entry 1rvf). The intact antibodies are much larger than the small fragments seen here, so seven to ten antibodies are enough to form a bulky barrier on each virus to block attachment and infection.
Exploring the Structure
Many structures of rhinovirus with antiviral drugs are available at the PDB, including the drug pleconaril, currently in clinical testing, shown here (PDB entry 1c8m). In this illustration, the drug is shown in spheres, and only four protein chains are shown, instead of the entire capsid. The inside of the virus is towards the bottom of the figure and the deep groove where the cellular receptor and antibodies bind can be seen on the upper side, shown with an arrow. Most drugs act by blocking protein binding sites or destabilizing a key interaction. These drugs, on the other hand, may act differently. They actually stabilize the virus structure so that it cannot release its cargo of RNA. The drugs bind in a little pocket under the deep groove that grabs onto the cellular receptor. Normally, the binding of virus to receptor shifts the structure of the virus, ultimately allowing the virus to release RNA. The drug, however, glues the virus shut.
Structures mentioned in this feature: 4rhv (Arnold, E., Rossmann, M.G. The use of molecular-replacement phases for the refinement of the human rhinovirus 14 structure. Acta Crystallogr., Sect.A v44 pp. [270] [271] [272] [273] [274] [275] [276] [277] [278] [279] [280] [281] [282] 1988) 2plv (Filman, D.J., Syed, R., Chow, M., Macadam, A.J., Minor, P.D., Hogle, J.M. Structural factors that control conformational transitions and serotype specificity in type 3 poliovirus EMBO J. v8 pp. [1567] [1568] [1569] [1570] [1571] [1572] [1573] [1574] [1575] [1576] [1577] [1578] [1579] 1989) 1bbt (Fry, E., Acharya, R., Stuart, D. Methods used in the structure determination of foot-and-mouth disease virus. Acta Crystallogr., Sect.A v49 pp. [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] 1993) 1dgi (He, Y., Bowman, V.D., Mueller, S., Bator, C.M., Bella, J., Peng, X., Baker, T.S., Wimmer, E., Kuhn, R.J., Rossmann, M.G. Interaction of the poliovirus receptor with poliovirus. Proc.Natl.Acad.Sci. USA v97 pp. [79] [80] [81] [82] [83] [84] 2000) 1rvf (Smith, T.J., Chase, E.S., Schmidt, T.J., Olson, N.H., Baker, T.S. Neutralizing antibody to human rhinovirus 14 penetrates the receptor-binding canyon. Nature v383 pp. [350] [351] [352] [353] [354] 1996) 
POLIOVIRUS AND RHINOVIRUS
